Soren Klim

Soborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose.

Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose.

Journal: Basic & clinical pharmacology & toxicology

Published: January 31, 2017

Impact of demographics and disease progression on the relationship between glucose and HbA1c.

Impact of demographics and disease progression on the relationship between glucose and HbA1c.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: October 20, 2016

Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches.

Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches.

Journal: CPT: pharmacometrics & systems pharmacology

Published: July 27, 2016

The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin Model.

The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin Model.

Journal: CPT: pharmacometrics & systems pharmacology

Published: September 08, 2014

A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.

A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 12, 2014

Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches.

Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches.

Journal: CPT: pharmacometrics & systems pharmacology

Published: December 26, 2013

Modeling of 24-hour glucose and insulin profiles in patients with type 2 diabetes mellitus treated with biphasic insulin aspart.

Modeling of 24-hour glucose and insulin profiles in patients with type 2 diabetes mellitus treated with biphasic insulin aspart.

Journal: Journal of clinical pharmacology

Published: December 10, 2013

Insulin degludec: pharmacokinetic properties in subjects with hepatic impairment.

Insulin degludec: pharmacokinetic properties in subjects with hepatic impairment.

Journal: Clinical drug investigation

Published: November 27, 2013

Insulin degludec: pharmacokinetics in patients with renal impairment.

Insulin degludec: pharmacokinetics in patients with renal impairment.

Journal: Clinical pharmacokinetics

Published: October 29, 2013

Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic Treatments.

Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic Treatments.

Journal: CPT: pharmacometrics & systems pharmacology

Published: April 03, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026